Zuna R E, Hansen K, Mann W
Department of Pathology, State University of New York, Stony Brook.
Acta Cytol. 1990 Sep-Oct;34(5):645-51.
The peritoneal washing cytologies of 109 patients (112 procedures) undergoing laparotomy for cervical carcinoma were evaluated retrospectively and compared with the clinical and pathologic findings. Nine patients (8.3%) had malignant peritoneal washings (including three of four with washings initially termed "inconclusive"). Four (4.9%) of the 82 patients with squamous carcinoma and 3 (16.7%) of 18 with adenocarcinoma had positive washings. Five (5.6%) of 90 washings obtained at initial explorations were positive, as compared with 4 (18.2%) of 22 washings obtained as follow-up operations in recurrent cases. The 111 peritoneal washing cytologies with a corresponding histologic evaluation of the peritoneal cavity showed a good correlation; peritoneal washing cytology had an efficiency of 91.0%, a sensitivity of 52.9% and a specificity of 100%. Two cases in which the cytologies were considered positive only after review had negative peritoneal histologies; both patients died of progressive disease within 11 months. Peritoneal washing cytology was positive in 5 (5.9%) of 84 cases with FIGO stage 1 cancers, 2 (18.2%) of 11 cases with stage 2 cancers, 1 (33.3%) of 3 cases with stage 3 cancers, and 1 (10%) of 10 cases with recurrent tumors. Eight (88.9%) of nine patients with malignant peritoneal washings died of disease from 3 to 15 months following surgery; one showed no evidence of disease at 9 months. These results suggest that: (1) cervical carcinomas are infrequently associated with a positive peritoneal washing; (2) peritoneal washing cytology is more likely to be positive in cases of adenocarcinoma than in cases of squamous carcinoma; (3) peritoneal washings obtained at the time of surgery for recurrence are more likely to contain malignant cells than are washings obtained during initial exploration; (4) nonkeratinizing malignant squamous cells may be confused with reactive mesothelial cells; and (5) peritoneal washing cytology is a relatively insensitive technique for detecting advanced cervical disease, but correlates with a poor prognosis when positive.
对109例(112次手术)因宫颈癌接受剖腹手术患者的腹腔冲洗细胞学检查结果进行回顾性评估,并与临床和病理结果进行比较。9例(8.3%)患者腹腔冲洗液呈恶性(包括最初判定为“不确定”的4例中的3例)。82例鳞状细胞癌患者中有4例(4.9%)冲洗液呈阳性,18例腺癌患者中有3例(16.7%)冲洗液呈阳性。初次探查时获取的90份冲洗液中有5份(5.6%)呈阳性,而复发病例后续手术获取的22份冲洗液中有4份(18.2%)呈阳性。111份腹腔冲洗细胞学检查结果与相应的腹腔组织学评估结果显示出良好的相关性;腹腔冲洗细胞学检查的有效率为91.0%,敏感性为52.9%,特异性为100%。2例细胞学检查结果经复查后才判定为阳性的患者,其腹腔组织学检查结果为阴性;这2例患者均在11个月内死于疾病进展。国际妇产科联盟(FIGO)1期癌症的84例患者中有5例(5.9%)腹腔冲洗细胞学检查呈阳性,2期癌症的11例患者中有2例(18.2%)呈阳性,3期癌症的3例患者中有1例(33.3%)呈阳性,复发性肿瘤的10例患者中有1例(10%)呈阳性。9例腹腔冲洗液呈恶性的患者中有8例(88.9%)在术后3至15个月死于疾病;1例在9个月时无疾病证据。这些结果表明:(1)宫颈癌很少与腹腔冲洗液阳性相关;(2)腺癌患者的腹腔冲洗细胞学检查比鳞状细胞癌患者更易呈阳性;(3)复发性手术时获取的腹腔冲洗液比初次探查时获取的冲洗液更可能含有恶性细胞;(4)非角化性恶性鳞状细胞可能与反应性间皮细胞混淆;(5)腹腔冲洗细胞学检查是检测晚期宫颈癌的相对不敏感技术,但阳性时与预后不良相关。